StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
99
This year
4
Publishing Date
2023 - 08 - 09
2
2023 - 02 - 01
1
2023 - 01 - 19
1
2022 - 12 - 22
1
2022 - 12 - 21
1
2022 - 12 - 13
1
2022 - 12 - 12
1
2022 - 12 - 05
2
2022 - 12 - 02
1
2022 - 11 - 28
1
2022 - 11 - 07
1
2022 - 10 - 25
1
2022 - 10 - 12
1
2022 - 10 - 05
1
2022 - 09 - 22
1
2022 - 09 - 07
1
2022 - 09 - 02
1
2022 - 08 - 31
1
2022 - 07 - 20
1
2022 - 06 - 06
2
2022 - 05 - 25
1
2022 - 05 - 19
1
2022 - 05 - 16
1
2022 - 04 - 27
1
2022 - 04 - 20
1
2022 - 03 - 14
1
2022 - 03 - 02
1
2022 - 03 - 01
1
2022 - 02 - 15
1
2022 - 02 - 14
1
2022 - 01 - 21
1
2022 - 01 - 14
1
2021 - 12 - 29
1
2021 - 12 - 10
1
2021 - 12 - 02
1
2021 - 11 - 23
1
2021 - 11 - 17
1
2021 - 11 - 11
1
2021 - 11 - 09
1
2021 - 11 - 01
1
2021 - 10 - 07
1
2021 - 09 - 24
1
2021 - 09 - 20
3
2021 - 09 - 19
1
2021 - 08 - 25
1
2021 - 08 - 05
1
2021 - 06 - 28
1
2021 - 06 - 24
1
2021 - 06 - 04
1
2021 - 06 - 01
1
2021 - 05 - 25
1
2021 - 04 - 20
1
2021 - 04 - 10
1
2021 - 03 - 31
1
2021 - 03 - 23
1
2021 - 03 - 10
1
2021 - 02 - 10
1
2021 - 02 - 04
1
2021 - 01 - 11
1
2021 - 01 - 04
1
Sector
Consumer services
1
Distribution services
1
Finance
9
Health services
2
Health technology
99
Manufacturing
1
Miscellaneous
1
Process industries
1
Professional, scientific, and technical services
1
Tags
Acquired
1
Acquisition
1
Advanced
1
Agreement
2
Alliances
4
America
1
Application
3
Approval
2
Artificial intelligence
1
Asco
2
Authorization
1
Biocapital
1
Biomarkers
2
Bioscience
3
Biotech-beach
12
Biotechnology
3
Breakthrough therapy
1
Cancer
32
Cancer drug
1
Care
2
Cel
1
Cell
4
Collaboration
5
Colorectal cancer
2
Conference
11
Designation
2
Diagnostic
3
Drug
5
Earnings
2
Events
2
Fda
5
Financial
7
Financial results
5
Food
3
Global
3
Grant
6
Health
3
Krasg12
12
Lung
11
Lung cancer
7
N/a
65
Nasdaq
5
New drug
2
Offering
4
Pharm-country
2
Phase 1
2
Positive
4
Report
8
Research
7
Results
25
Sapphire
2
Study
4
System
2
Test
3
Therapeutics
49
Therapy
4
Treatment
9
Tumors
4
Update
3
World
2
Entities
Aadi biosciences inc
1
Abbvie inc.
1
Absci corp
1
Agenus inc.
1
Agilent technologies, inc.
1
Amgen inc.
3
Amneal pharmaceuticals, inc.
1
Biontech se
1
Blueprint medicines corporation
2
Bristol-myers squibb company
10
Corcept therapeutics incorporated
1
Eli lilly and company
4
Entasis therapeutics holdings inc.
1
Evercore inc.
1
Firstcash, inc.
1
Genmab a/s
1
Gilead sciences, inc.
1
Glaxosmithkline plc
1
Incyte corporation
3
Johnson & johnson
2
Karuna therapeutics, inc.
4
Kura oncology, inc.
1
Mckesson corporation
1
Merck & company, inc.
1
Merrimack pharmaceuticals, inc.
1
Mirati therapeutics, inc.
99
Moderna, inc.
1
Morgan stanley
6
Neogenomics, inc.
1
Novocure limited
2
Oak street health, inc.
1
Oncolytics biotech inc.
2
Oric pharmaceuticals, inc.
1
Phathom pharmaceuticals, inc.
1
Ppg industries, inc.
1
Purple innovation, inc.
1
Qiagen n.v.
2
Rayzebio, inc.
1
Revolution medicines, inc.
1
Rollins, inc.
1
Sanofi
3
Seagen inc.
2
Seer inc - class a
1
Turning point therapeutics, inc.
1
Uniqure n.v.
1
Verastem, inc.
1
X financial
2
Zai lab limited
5
Symbols
AAPL
1193
ABB
1200
ABBV
608
ABLZF
1162
ABT
1073
ACAQ
522
AMGN
742
AMSIY
464
AMSYF
464
ARCXF
464
ARVL
4285
AVGO
585
AZN
664
BNPQF
1764
BNPQY
1764
CRCW
472
CSCO
895
DNZOF
504
DNZOY
504
ERIC
1607
EXTR
581
FNCTF
7171
FRBA
595
GE
508
GILD
499
GLAXF
657
GOOG
1274
GOOGL
1273
GSK
810
HON
1020
IFNNF
524
IFNNY
502
INTC
954
JNJ
2063
LLY
1087
LTUM
970
MAR
474
MDT
731
MS
1786
MSFT
1199
MT
472
NIPNF
533
NOK
856
NOKBF
972
NVDA
516
NVS
1156
NVSEF
1031
ORCL
786
PCRFF
650
PCRFY
650
PHG
476
PPRUF
1126
PPRUY
1127
SAP
1376
SAPGF
1228
SNY
4532
SNYNF
3590
TEVJF
630
TMO
705
VSAC
533
Exchanges
Nasdaq
99
Nyse
24
Crawled Date
2023 - 08 - 09
2
2023 - 02 - 03
1
2023 - 02 - 01
1
2023 - 01 - 19
1
2022 - 12 - 22
1
2022 - 12 - 21
1
2022 - 12 - 13
2
2022 - 12 - 06
2
2022 - 12 - 02
1
2022 - 11 - 28
1
2022 - 11 - 07
1
2022 - 10 - 25
1
2022 - 10 - 12
1
2022 - 10 - 05
1
2022 - 09 - 22
1
2022 - 09 - 07
1
2022 - 09 - 02
1
2022 - 08 - 31
1
2022 - 07 - 20
1
2022 - 06 - 06
2
2022 - 05 - 25
1
2022 - 05 - 19
1
2022 - 05 - 16
1
2022 - 04 - 27
1
2022 - 04 - 20
1
2022 - 03 - 14
1
2022 - 03 - 02
1
2022 - 03 - 01
1
2022 - 02 - 15
1
2022 - 02 - 14
1
2022 - 01 - 21
1
2022 - 01 - 14
1
2021 - 12 - 30
1
2021 - 12 - 10
1
2021 - 12 - 02
1
2021 - 11 - 23
1
2021 - 11 - 17
1
2021 - 11 - 11
1
2021 - 11 - 09
1
2021 - 11 - 01
1
2021 - 10 - 07
1
2021 - 09 - 25
1
2021 - 09 - 20
3
2021 - 09 - 19
1
2021 - 08 - 25
1
2021 - 08 - 05
1
2021 - 06 - 28
1
2021 - 06 - 24
1
2021 - 06 - 04
1
2021 - 06 - 01
1
2021 - 05 - 26
1
2021 - 04 - 20
1
2021 - 04 - 10
1
2021 - 03 - 31
1
2021 - 03 - 23
1
2021 - 03 - 10
1
2021 - 02 - 10
1
2021 - 02 - 05
1
2021 - 01 - 11
1
2021 - 01 - 04
1
Crawled Time
00:00
4
00:20
1
01:00
2
04:20
1
05:00
1
06:00
1
09:00
1
10:00
1
11:00
2
12:00
6
12:15
1
12:30
1
13:00
7
13:15
1
13:20
1
13:30
1
14:00
1
14:15
2
14:30
2
15:00
1
15:30
1
16:00
1
16:20
1
17:00
2
18:00
1
19:00
3
20:00
12
20:20
1
21:00
18
22:00
11
22:04
1
23:00
8
23:07
1
Source
www.biospace.com
34
www.globenewswire.com
8
www.prnewswire.com
57
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
MRTX
exchanges :
Nasdaq
save search
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
Published:
2024-02-02
(Crawled : 14:30)
- biospace.com/
RYZB
|
$62.49
0.03%
280K
|
|
0.64%
|
O:
0.03%
H:
0.11%
C:
0.0%
XYF
|
$3.79
-0.78%
0.0%
1K
|
Finance
|
-1.04%
|
O:
1.04%
H:
1.79%
C:
-1.23%
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
-0.84%
|
O:
1.23%
H:
1.5%
C:
-1.14%
KRTX
|
$329.83
0.0%
1.9M
|
Health Technology
|
5.24%
|
O:
0.06%
H:
0.0%
C:
0.0%
financial
results
Corcept Appoints Roberto Vieira as President, Oncology
Published:
2024-01-29
(Crawled : 13:00)
- globenewswire.com
CORT
M
|
$23.0
-1.67%
-1.7%
960K
|
Health Technology
|
7.99%
|
O:
0.6%
H:
2.48%
C:
2.48%
Bristol Myers Squibb Completes Acquisition of Mirati Therapeutics, Strengthening and Diversifying Oncology Portfolio
Published:
2024-01-23
(Crawled : 14:30)
- biospace.com/
MS
|
News
0 d
|
$90.08
1.06%
-0.28%
9.5M
|
Finance
|
5.47%
|
O:
-0.07%
H:
1.38%
C:
1.25%
EVR
|
$185.5
0.45%
0.0%
360K
|
Finance
|
5.36%
|
O:
0.35%
H:
0.29%
C:
-0.26%
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
-2.64%
|
O:
0.22%
H:
1.49%
C:
0.89%
acquisition
European Commission Approves KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation
Published:
2024-01-10
(Crawled : 13:00)
- prnewswire.com
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
-0.31%
|
O:
0.02%
H:
0.17%
C:
-0.19%
krasg12
lung
cancer
cell
treatment
advanced
Mirati Therapeutics Receives Positive Opinion from CHMP for KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation Following a Re-Examination Procedure
Published:
2023-11-10
(Crawled : 12:30)
- prnewswire.com
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
-4.27%
|
O:
0.4%
H:
0.18%
C:
0.0%
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
4.61%
|
O:
-0.11%
H:
0.0%
C:
0.0%
krasg12
lung
chmp
positive
cancer
cell
treatment
therapeutics
Zai Lab Announces Third Quarter 2023 Financial Results and Recent Corporate Updates
Published:
2023-11-07
(Crawled : 21:00)
- globenewswire.com
GNMSF
|
$285.11
3.83%
420
|
Health Technology
|
-1.94%
|
O:
6.62%
H:
2.29%
C:
-0.06%
ZLAB
|
$13.75
-4.65%
-4.87%
400K
|
Health Technology
|
-49.06%
|
O:
8.3%
H:
0.02%
C:
-2.12%
SGEN
|
$228.74
0.1%
20M
|
Health Technology
|
6.91%
|
O:
0.49%
H:
0.0%
C:
-0.57%
NVCR
|
$12.04
-3.37%
-3.49%
1.4M
|
Health Technology
|
-3.19%
|
O:
0.7%
H:
0.0%
C:
-6.94%
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
4.89%
|
O:
0.29%
H:
0.21%
C:
-0.48%
KRTX
|
$329.83
0.0%
1.9M
|
Health Technology
|
83.73%
|
O:
0.27%
H:
0.14%
C:
-3.34%
GMAB
|
$28.51
-3.13%
-3.23%
360K
|
Health Technology
|
-0.3%
|
O:
7.35%
H:
0.44%
C:
-2.18%
results
Mirati Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Updates
Published:
2023-11-06
(Crawled : 15:00)
- biospace.com/
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
-8.63%
|
O:
0.61%
H:
0.77%
C:
-0.66%
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
5.6%
|
O:
0.75%
H:
0.59%
C:
0.27%
therapeutics
financial
results
Kura Oncology and Mirati Therapeutics Enter into Clinical Collaboration and Supply Agreement to Evaluate KO-2806 and Adagrasib in KRASᴳ¹²ᶜ-Mutated NSCLC
Published:
2023-11-02
(Crawled : 12:00)
- globenewswire.com
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
-5.89%
|
O:
-0.9%
H:
1.08%
C:
0.61%
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
5.41%
|
O:
0.2%
H:
0.43%
C:
-0.38%
KURA
|
$18.0
-3.17%
-3.28%
660K
|
Health Technology
|
132.67%
|
O:
0.13%
H:
6.0%
C:
5.25%
ko-2806
collaboration
therapeutics
agreement
Bristol Myers Squibb Prices $4.5 Billion of Senior Unsecured Notes
Published:
2023-10-31
(Crawled : 06:00)
- biospace.com/
MS
|
News
0 d
|
$90.08
1.06%
-0.28%
9.5M
|
Finance
|
28.95%
|
O:
0.83%
H:
0.0%
C:
0.0%
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
-5.83%
|
O:
0.25%
H:
0.54%
C:
0.29%
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
6.12%
|
O:
0.46%
H:
0.0%
C:
0.0%
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
Published:
2023-10-26
(Crawled : 13:00)
- biospace.com/
XYF
|
$3.79
-0.78%
0.0%
1K
|
Finance
|
-2.55%
|
O:
-3.19%
H:
4.87%
C:
4.87%
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
-14.75%
|
O:
-4.68%
H:
2.46%
C:
-1.83%
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
6.54%
|
O:
0.16%
H:
0.47%
C:
0.2%
financial
results
Mirati Presents Late-Breaking Results Evaluating the Combination of Adagrasib and Pembrolizumab in First-Line Non-Small Cell Lung Cancer (NSCLC)
Published:
2023-10-17
(Crawled : 20:00)
- prnewswire.com
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
3.98%
|
O:
-0.04%
H:
0.35%
C:
-0.53%
lung
cancer
cell
results
Pancreatic Cancer Battle Boosted by $200M VC Firm
Published:
2023-09-19
(Crawled : 17:00)
- prnewswire.com
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-46.08%
|
O:
-1.47%
H:
4.98%
C:
3.98%
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
84.91%
|
O:
-0.13%
H:
2.0%
C:
1.83%
MACK
4
|
$14.68
0.0%
100K
|
Health Technology
|
19.93%
|
O:
-0.41%
H:
0.9%
C:
0.74%
INCY
|
$52.74
-0.9%
-0.91%
2.5M
|
Health Technology
|
-10.57%
|
O:
0.03%
H:
2.18%
C:
1.8%
BNTX
|
$86.42
0.09%
0.09%
1.2M
|
Health Technology
|
-20.82%
|
O:
-0.01%
H:
1.99%
C:
1.28%
cancer
pancreatic
Mirati Presents Two-Year Follow-Up Data from KRYSTAL-1 Study Demonstrating Durable Response and Long-Term Overall Survival at 2023 World Conference on Lung Cancer
Published:
2023-09-10
(Crawled : 04:20)
- prnewswire.com
MS
|
News
0 d
|
$90.08
1.06%
-0.28%
9.5M
|
Finance
|
Email alert
Add to watchlist
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
Email alert
Add to watchlist
lung
conference
world
cancer
response
study
Mirati Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Published:
2023-09-05
(Crawled : 20:00)
- prnewswire.com
MS
|
News
0 d
|
$90.08
1.06%
-0.28%
9.5M
|
Finance
|
5.32%
|
O:
-1.87%
H:
0.0%
C:
0.0%
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
64.44%
|
O:
0.36%
H:
0.86%
C:
-1.17%
nasdaq
grant
therapeutics
Mirati Therapeutics to Participate at the Morgan Stanley 21st Annual Global Healthcare Conference
Published:
2023-08-29
(Crawled : 20:00)
- prnewswire.com
MS
|
News
0 d
|
$90.08
1.06%
-0.28%
9.5M
|
Finance
|
7.02%
|
O:
1.44%
H:
0.0%
C:
0.0%
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
61.37%
|
O:
0.69%
H:
1.04%
C:
1.01%
conference
global
therapeutics
Mirati To Present Pooled Clinical Data from Adagrasib's KRYSTAL-1 Study Demonstrating Overall Survival Results at Two-Years of Follow-Up at 2023 World Conference on Lung Cancer
Published:
2023-08-21
(Crawled : 20:00)
- prnewswire.com
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
55.36%
|
O:
0.5%
H:
1.29%
C:
-1.02%
lung
conference
world
cancer
results
study
Mirati Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
Published:
2023-08-11
(Crawled : 20:00)
- prnewswire.com
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
Email alert
Add to watchlist
offering
therapeutics
Mirati Therapeutics Announces Pricing of Upsized Public Offering - August 09, 2023
Published:
2023-08-09
(Crawled : 11:00)
- biospace.com/
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
109.7%
|
O:
23.42%
H:
8.46%
C:
6.87%
offering
therapeutics
Mirati Therapeutics Announces Pricing of Upsized Public Offering
Published:
2023-08-09
(Crawled : 05:00)
- prnewswire.com
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
109.7%
|
O:
23.42%
H:
8.46%
C:
6.87%
offering
therapeutics
Mirati Therapeutics® to Report Second Quarter 2023 Financial Results and Recent Corporate Updates on August 8, 2023
Published:
2023-07-25
(Crawled : 21:00)
- prnewswire.com
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
92.47%
|
O:
0.29%
H:
0.0%
C:
-2.19%
therapeutics
report
financial
results
← Previous
1
2
3
4
5
Next →
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.